SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
Stay updated with breaking news from Surmodics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...
Surmodics (NASDAQ:SRDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday. SRDX has been the topic of a number of other reports. Sidoti restated a “neutral” rating and issued a $43.00 target price on shares of Surmodics in a report on Wednesday. […]
-- SurModics has an average rating of outperform and price targets ranging from $43 to $75, according to analysts polled by Capital IQ. Price: 42.19, Change: +7.09, Percent Change: +20.20 ...
Surmodics, Inc. , a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered into a definitive agreement to be acquired by GTCR,...